Lexaria Bioscience (NASDAQ:LEXX) Releases Quarterly Earnings Results
Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) issued its quarterly earnings results on Friday. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.04), Zacks reports. Lexaria Bioscience had a negative net margin of 1,249.14% and a negative return on equity of 86.10%. Lexaria Bioscience Price Performance Shares of […]
12 Jan 07:08 · The Cerbat Gem